JPMORGAN CHASE & CO - FIVE PRIME THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

FIVE PRIME THERAPEUTICS INC's ticker is and the CUSIP is 33830X954. A total of 2 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$214,000
+189.2%
35,000
+7.7%
0.00%–
Q1 2020$74,000
-86.2%
32,500
-18.8%
0.00%–
Q1 2019$536,000
-37.6%
40,000
-20.0%
0.00%–
Q1 2018$859,000
-58.6%
50,0000.0%0.00%
-100.0%
Q4 2015$2,075,000–50,000–0.00%–
 Download
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 26,000$411,0000.00%
SIMPLEX TRADING, LLC 6$9,0000.00%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders